{
  "trial_id": "NCT00490529",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, ECOG Performance Status, Karnofsky Performance Scale, HIV status, Disease stage, Prior treatments, Peripheral blood tumor count, Medical history, Psychological status, Pregnancy status",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Karnofsky Performance Scale",
          "Karnofsky Performance Scale"
        ],
        [
          "HIV status",
          "HIV-negative"
        ],
        [
          "Pregnancy status",
          "Pregnant or lactating"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Disease stage",
        "Prior treatments",
        "Peripheral blood tumor count",
        "Medical history",
        "Psychological status"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, ECOG Performance Status, Karnofsky Performance Scale, HIV Status, Prior Chemotherapy, Prior Rituximab Therapy, Tumor Burden,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ],
        [
          "HIV Status",
          "HIV Status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Scale",
        "Prior Chemotherapy",
        "Prior Rituximab Therapy",
        "Tumor Burden"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Karnofsky Performance Scale, HIV Status, Lymphoma Stage, Lymphoma Cell Count, Prior Chemotherapy, Prior Rituximab Treatment,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "ECOG Performance Status",
        "Karnofsky Performance Scale",
        "HIV Status",
        "Lymphoma Stage",
        "Lymphoma Cell Count",
        "Prior Chemotherapy",
        "Prior Rituximab Treatment"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, ECOG Performance Status, Karnofsky performance scale, HIV status, disease stage, prior therapy, time since diagnosis, lymphoma cell count, peripheral blood tumor cell count, rituximab treatment history, chemotherapy treatment history, autologous hematopoietic cell transplant (AHCT) history, comorbidities, performance status at diagnosis.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "ECOG Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Karnofsky performance scale",
          "Karnofsky performance scale"
        ],
        [
          "HIV status",
          "HIV status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "disease stage",
        "prior therapy",
        "time since diagnosis",
        "lymphoma cell count",
        "peripheral blood tumor cell count",
        "rituximab treatment history",
        "chemotherapy treatment history",
        "autologous hematopoietic cell transplant (AHCT) history",
        "comorbidities",
        "performance status at diagnosis."
      ]
    }
  }
}